Real-world safety of rapid 30-minute intravenous isatuximab infusion in multiple myeloma: results from the largest published cohort - Poll - MDSpire

Real-world safety of rapid 30-minute intravenous isatuximab infusion in multiple myeloma: results from the largest published cohort

  • By

  • Xabier Gutiérrez López De Ocáriz

  • Ernesto Pérez Persona

  • Laura Salcedo Cuesta

  • Eusebio Martín Chacón

  • Maialen Sirvent Auzmendi

  • Pamela Millacoy Austerrritt

  • Marcos Lorenzo Pérez

  • Elena Landete Hernández

  • Vicente Carrasco Baraja

  • Irene Sanchéz Romero

  • Tania Ivett Arámbula

  • Ianire Etxeguren Urkixo

  • July 9, 2026

  • 0 min

Share

Original Source(s)

Real-world safety of rapid 30-minute intravenous isatuximab infusion in multiple myeloma: results from the largest published cohort

  • by Xabier Gutiérrez López De Ocáriz, Ernesto Pérez Persona, Laura Salcedo Cuesta, Eusebio Martín Chacón, Maialen Sirvent Auzmendi, Pamela Millacoy Austerrritt, Marcos Lorenzo Pérez, Elena Landete Hernández, Vicente Carrasco Baraja, Irene Sanchéz Romero, Tania Ivett Arámbula, Ianire Etxeguren Urkixo

  • July 9, 2026

Related Content

Global burden and temporal trends of kidney cancer among children from 1990 to 2021: an analysis with projections to 2036

Translating physical stress into biological signals: precision electro-oncology based on conformational changes of electro-sensitive receptors and parameterized immune remodeling

The Journey of a Sample

Rethinking sustainability in the complex world of clinical trials

  • July 8, 2026

  • 9 min